Skip to Main Content

Advanced Cardiovascular Magnetic Resonance for Detection of Programmed Cell Death Protein-1 Deficient Myocarditis

What is the purpose of this trial?

We hypothesize that advanced CMR can detect myocardial structural, functional, and metabolic changes associated with autoimmune myocarditis in cardio-toxicity associated with CPI therapy of the PD-1 pathway in cancer patients. We propose to do this by applying advanced CMR methods for edema and fibrosis to detect early inflammation and cardio-toxicity in patients receiving CPI therapy.

  • Trial with
    American Heart Association
  • Start Date
    10/28/2018
  • End Date
    09/29/2022
Trial Image

For more information about this study, contact:

Elio Ragheb

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    11/05/2018
  • Study HIC
    #2000023943